8,210
-1.56%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About GemVax & KAEL Co
Its shares trade on KOSDAQ under the ticker 082270.KQ. It has been listed since 24 June 2005. In the fiscal year to 31 December 2025, it reported revenue of ₩81.53bn and a net loss of ₩11.34bn. At that date it held total assets of ₩158.87bn and shareholders' equity of ₩57.23bn.
GemVax & KAEL Co., Ltd. engages in the production of chemical filters and gas scrubbers for semiconductors. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2005-06-24. The firm and its subsidiaries are engaged in the three categories of businesses: pollution control business, which manufactures chemical air (CA) filters, gas scrubbers, resins, coating resins and other environmental equipments and systems; anticancer and anti-inflammation business, which engages in development of cancer vaccines for infectious diseases, such as acquired immune deficiency syndrome (AIDS) and anti-inflammations, and IT business which mainly produces liquid crystal display (LCD) modules. The firm distributes its products within domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Information Technology
- Industry
- Semiconductors & Semiconductor Equipment
- Listed since
- 24 Jun 2005
- Website
- gemvax.com ↗
Leadership
Pay as last reported
- Mr. Gi Ho KimChief Executive Officer, Director, since 2023
- Mr. Chang Ro LeeInternal Auditor
- Mr. Gi Wung KimDirector
- Mr. Dong Hui LeeDirector
- Mr. Se Yeol LeeNon-Executive Independent Director
- Mr. Bong Gwon ParkNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- GemVax & KAEL Co Ltd produces chemical filters for semiconductor manufacturing in Daejeon, South Korea.
- The company's pollution control business includes gas scrubbers and environmental systems for semiconductors.
- GemVax & KAEL Co Ltd develops cancer vaccines for infectious diseases like AIDS in South Korea.
Weaknesses
- GemVax & KAEL Co Ltd focuses on limited semiconductor-related products like filters and scrubbers.
- The company's anticancer business is limited to vaccine development for specific diseases.
- GemVax & KAEL Co Ltd has no mention of international market expansion beyond current distribution.
Opportunities
- GemVax & KAEL Co Ltd can expand its pollution control business to global semiconductor markets.
- The company has potential to grow its anticancer business with new vaccine development.
- GemVax & KAEL Co Ltd can leverage its LCD module production for IT business growth.
Threats
- GemVax & KAEL Co Ltd faces competition from semiconductor equipment suppliers in South Korea.
- The company's reliance on semiconductor industry may be affected by market downturns.
- GemVax & KAEL Co Ltd's anticancer business could face regulatory challenges in vaccine development.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.